Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1983-12-20
1985-10-15
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Lymphokine
435235, A61K 3929
Patent
active
045473676
ABSTRACT:
Disclosed is a vaccine against hepatitis B virus (HBV) using purified hepatitis B core antigen (HBcAg). Chimpanzees immunized with the vaccine were protected against hepatitis B.
REFERENCES:
patent: 4100267 (1978-07-01), Shaw
patent: 4102996 (1978-07-01), McAleer et al.
Tabor et al., Lancet, Jan. 21, 1984, p. 172.
Tabor et al., Transfusion, 21(3), May/Jun. 1981, pp. 366-371.
Tabor et al., J. Med. Virol., 6:91-99, (1980).
Neurath et al., J. Gen. Virol., 42:645-649, (1979).
Hoofnagle, N. Eng. J. Med., 298(25):1379-1383, Jun. 22, 1978.
Purcell et al., Am. J. Clin. Pathol., Jul. 1978, pp. 159-169.
Hansson, J. Clin. Microbiol., 6(3):209-211, Sep. 1977.
Tabor et al., J. Immunol., 117(5), (Part 2): 2038-2040, Nov. 1976.
Hoofnagle, Am. J. Med. Sci., 270(1):179-187, (1975).
Hoofnagle, Develop. Biol. Stand., 30:175-185, (1975).
Krugman, Develop. Biol. Stand., 30:363-367, (1975).
Krugman, N. Engl. J. Med., 290:1331-1335, Jun. 13, 1974.
Barker et al., Adv. Int. Med., 23:327-351, (1976).
Shaw et al., Journal of Virology, 12:1598, (1973).
Hoofnagle et al., The New England Journal of Medicine, 290:1336, (1974).
Hoofnagle et al., Lancet, 2:869, (1973).
Barker et al., J. of Virology, 14:1552, (1974).
Gerety Robert J.
Tabor Edward
Roberts, Jr. John S.
Rose Shep K.
The United States of America as represented by the Department of
LandOfFree
Hepatitis B core antigen vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hepatitis B core antigen vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis B core antigen vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2431593